We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The test identified residual disease in non-small cell lung, bladder, breast and colorectal cancer patients up to two years earlier than standard imaging. Read More